Variable | Overall survival | Progression free survival | ||
Average (months) | p | Average (months) | p | |
Age <50 years >50 years |
129.1 161.4 |
0.49 |
57.5 104.6 |
0.76 |
Menopause Yes No |
183.9 107 |
0.53 |
115.3 51.8 |
0.88 |
Family history of cancer Yes No |
185.2 105.2 |
0.71 |
36.7 108.7 |
0.90 |
Site Right breast Left breast |
93.5 211.2 |
0.09 |
72.7 106.3 |
0.89 |
SBR grade II III |
NA NA |
NA |
31.3 110.8 |
0.48 |
Intra-ductal component Yes No |
143.6 147.1 |
0.14 |
94 84.1 |
0.24 |
Vascular emboli Yes No |
67.9 181.8 |
0.52 |
67.3 96.1 |
0.34 |
Mesenchymal component Yes No |
118.2 176.1 |
0.93 |
60 94.2 |
0.4 |
Tumor size <3 cm >3 cm |
128.8 172.6 |
0.4 |
52.7 114.3 |
0.63 |
T stage T1 - T2 T3 - T4 |
121.3 173.7 |
0.72 |
70 110.4 |
0.64 |
pN stage N0 N1 N2 N3 |
143.4 157.5 24 18.5 |
0.001 |
88.8 147.3 15.7 7.5 |
0.002 |
Lymph node metastasis Absent Present |
143.4 106.3 |
0.02 |
88.8 94.8 |
0.13 |
Clinical stage I/II III/IV |
119.2 199.7 |
0.71 |
72.1 132.3 |
0.8 |
Estrogen receptors Positive Negative |
NA NA |
NA |
55 107.3 |
0.35 |
Progesterone receptors Positive Negative |
NA NA |
NA |
55 107.3 |
0.35 |